We use cookies for a better user experience. Read our Privacy Policy

I Agree

Substance Abuse Treatment Market

Substance Abuse Treatment Market (Abuse Type - Alcohol Dependence, Tobacco/Nicotine Addiction, and Opioid Addiction; Treatment Type - Alcohol Addiction Treatment (Disulfiram, Acamprosate, and Naltrexone), Tobacco/Nicotine Addiction Treatment (Nicotine Replacement Treatment and Non-nicotine Medication), Drug Abuse Treatment (Methadone, Buprenorphine, and Naltrexone); End User - Outpatient Treatment Centers, Residential Treatment Centers, and Inpatient Treatment Centers) - U.S. Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

U.S. Substance Abuse Treatment Market: Snapshot 

In the U.S. Substance abuse has become a major cause of concern. People in this country are increasingly getting addicted to a variety of drugs, affecting their health and their family life to a large extent. With prolonged drug and alcohol abuse, the prevalence of mental illness and various chronic diseases, such as diabetes and cardiovascular disorders, have increased substantially among consumers, creating a high economic burden on the nation. To control this situation, the U.S. government is focusing on adopting the early intervention as well as prevention strategies, which is expected to drive significant demand for substance abuse treatments, reflecting impressively on the U.S. substance abuse treatment market. 

Currently, all medications used in the treatments of people struggling with substance abuse have been thoroughly examined by the FDA and found to be highly efficient when used properly, under the direction of the prescribing physician. The market is also anticipated to gain remarkably from this in the near future. In 2015, the market was worth US$4.42 bn. Estimated to expand at a CAGR of 12.40% between 2016 and 2024 and reach a value of US$12.43 bn by the end of 2024. 

us substance abuse treatment market

Drug Abuse Treatment Dominates U.S. Substance Abuse Treatment Market 

Alcohol dependence, tobacco/nicotine addiction, and opioid addiction are the main types of substance addiction, a number of U.S. citizens have fallen prey to. With around 15% of the overall population in the U.S. addicted to smoking, the tobacco/nicotine addiction takes the lead among the types of substance abuse taking place in the U.S. 

The key treatments for substance abuse, applied in the U.S., are alcohol addiction treatment, tobacco or Nicotine addiction treatment and drug abuse treatment. Drug abuse treatment reports a higher demand from end users than other substance abuse treatments. Analysts expect this scenario to remain same over the next few years. Methadone, buprenorphine, and naltrexone are the main types of drug abuse treatments utilized in this country. Product innovation in buprenorphine pills and film, and the recent launch of buprenorphine implants is likely to boost the drug abuse treatment segment remarkably in the near future. 

Disulfiram, acamprosate, and naltrexone are the most widely preferred drugs for the treatment of patients struggling with alcohol addiction. Acamprosate is expected to account for the most prominent share among these drugs over the forthcoming years. Nicotine replacement treatment and non-nicotine medications have emerged as the most effective treatments for tobacco or nicotine addiction. 

Thanks to Increasing Popularity of Outpatient Rehab, Outpatient Treatment Centers to Remain Lead among End Users

Outpatient treatment centers, residential treatment centers, and inpatient treatment centers have surfaced as the key end users of the substance abuse treatment in the U.S. Among these, the demand for these treatments is higher in outpatient treatment centers and is anticipated to remain so over the coming years, thanks to the rising popularity of outpatient rehab across the country. 

The U.S. substance abuse treatment market is highly fragmented with a large number of companies operating in it. The prominent ones in them are Mallinckrodt, Purdue Pharma L.P., Sanofi, Dr. Reddy’s Laboratories Ltd., Pfizer Inc., GlaxoSmithKline Plc, Cipla Ltd., Allergan Plc, and Alkermes.

The U.S. substance abuse treatment market is segmented as follows: 

By Abuse Type

  • Alcohol Dependence
  • Tobacco/Nicotine Addiction
  • Opioid Addiction 

By Treatment

  • Alcohol Addiction Treatment
    • Disulfiram
    • Acamprosate
    • Naltrexone
  • Tobacco/Nicotine Addiction Treatment
  • Nicotine Replacement Treatment
    • Nicotine Patch
    • Nicotine Gum
    • Nicotine Lozenge
    • Nicotine Spray
    • Nicotine Inhaler
  • Non-Nicotine Medication
    • Bupropion
    • Varenicline
  • Drug Abuse Treatment
    • Methadone
    • Buprenorphine
    • Naltrexone 

By End User

  • Outpatient Treatment Centers
  • Residential Treatment Centers
  • Inpatient Treatment Centers 

By Geography

  • The U.S.

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

1. Preface

2. Assumptions and Research Methodology

3. Executive Summary

4. Market Overview
      4.1 Market Dynamics
      4.2 U.S. Substance Abuse Treatment Market, 2016–2024
      4.3 Key Trends
      4.4 Market Value Projections, 2014–2024
      4.5 Substance Abuse Treatment Market - U.S. Supply Demand-Scenario
      4.6 Porter’s Five Force Analysis
      4.7 Value Chain Analysis
      4.8 Policies and Regulations

5 U.S. Substance Abuse Treatment Market Analysis and Forecasts, BY Abuse Type

6 U.S. Substance Abuse Treatment Market Analysis and Forecasts, By Treatment Type
      6.1 Alcohol Addiction Treatment
      6.2 Tobacco/Nicotine Addiction Treatment
      6.3 Opioid Abuse Treatment
      6.4 Market Attractiveness By Treatment Type

7 U.S. Substance Abuse Treatment Market Analysis and Forecasts, By End User

8 Competition Landscape
      8.1 Alkermes
            8.1.1. Company Details
            8.1.2. Business Overview
            8.1.3. Financial Overview
            8.1.4. Strategy Overview
            8.1.5. SWOT Analysis
      8.2 Allergan plc
            8.2.1. Company Details
            8.2.2. Business Overview
            8.2.3. Financial Overview
            8.2.4. Strategy Overview
            8.2.5. SWOT Analysis
      8.3 Cipla Ltd
            8.3.1. Company Details
            8.3.2. Business Overview
            8.3.3. Financial Overview
            8.3.4. Strategy Overview
            8.3.5. SWOT Analysis
      8.4 GlaxoSmithKline plc 
            8.4.1. Company Details
            8.4.2. Business Overview
            8.4.3. Financial Overview
            8.4.4. Strategy Overview
            8.4.5. SWOT Analysis
      8.5 Pfizer, Inc.
            8.5.1. Company Details
            8.5.2. Business Overview
            8.5.3. Financial Overview
            8.5.4. Strategy Overview
            8.5.5. SWOT Analysis
      8.6 Dr. Reddy’s Laboratories Ltd.
            8.6.1. Company Details
            8.6.2. Business Overview
            8.6.3. Financial Overview
            8.6.4. Strategy Overview
            8.6.5. SWOT Analysis
      8.7 Sanofi 
            8.7.1. Company Details
            8.7.2. Business Overview
            8.7.3. Financial Overview
            8.7.4. Strategy Overview
            8.7.5. SWOT Analysis
      8.8 Purdue Pharma L.P.
            8.8.1. Company Details
            8.8.2. Business Overview
            8.8.3. Financial Overview
            8.8.4. Strategy Overview
            8.8.5. SWOT Analysis
      8.9 Mallinckrodt
            8.9.1. Company Details
            8.9.2. Business Overview
            8.9.3. Financial Overview
            8.9.4. Strategy Overview
            8.9.5. SWOT Analysis

List of Tables

Table 01: U.S. Substance Abuse Treatment Market Size (US$ Mn) Forecast, by Treatment Type, 2016–2024
Table 02: U.S. Substance Abuse Treatment Market Size (US$ Mn) Forecast, by Alcohol Addiction Treatment, 2016–2024
Table 03: U.S. Substance Abuse Treatment Market Size (US$ Mn) Forecast, By Tobacco/Nicotine Addiction Treatment,
Table 04: U.S. Substance Abuse Treatment Market Size (US$ Mn) Forecast, by Drug Abuse Treatment, 2016–2024
Table 05: U.S. Substance Abuse Treatment Market Size (US$ Mn) Forecast, by End-user, 2016–2024

List of Figures

Figure 01: U.S. Substance Abuse Treatment Market Value (US$ Mn) & Growth Forecast, 2015–2024
Figure 02: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Alcohol Addiction Treatment
Figure 03: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Tobacco/Nicotine Addiction Treatment
Figure 04: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, Drug Abuse Treatment
Figure 05: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Disulfiram
Figure 06: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Acamprosate
Figure 07: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, Naltrexone
Figure 08: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, By Nicotine Replacement Treatment
Figure 09: U.S. Substance Abuse Treatment Market Value Forecast, 2016 – 2024 and Y-o-Y growth projection, 2015 – 2024, By Non-Nicotine Medication
Figure 10: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Methadone
Figure 11: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Buprenorphine
Figure 12: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, Naltrexone
Figure 13: Substance Abuse Treatment Market Attractiveness Analysis, by Treatment Type, 2016–2024
Figure 14: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Outpatient Treatment Centers
Figure 15: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Residential Treatment Centers
Figure 16: U.S. Substance Abuse Treatment Market Value Forecast, 2015–2024 and Y-o-Y Growth Projection, 2016–2024, by Inpatient Treatment Centers
Figure 17: Substance Abuse Treatment Market Attractiveness Analysis, by End-user, 2016–2024

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved